• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用乳房定位装置在FDG-PET癌症筛查中改善乳腺癌的检测。

Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device.

作者信息

Kaida Hayato, Ishibashi Masatoshi, Fujii Teruhiko, Kurata Seiji, Ogo Etsuyo, Tanaka Maki, Hayabuchi Naofumi

机构信息

Division of Nuclear Medicine, PET Center and Department of Radiology, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, Fukuoka 830-0011, Japan.

出版信息

Ann Nucl Med. 2008 Feb;22(2):95-101. doi: 10.1007/s12149-007-0092-1. Epub 2008 Mar 3.

DOI:10.1007/s12149-007-0092-1
PMID:18311533
Abstract

OBJECTIVE

The aim of this study was to investigate the detection rate of breast cancer by positron emission tomography cancer screening using a breast positioning device.

METHODS

Between January 2004 and January 2006, 1,498 healthy asymptomatic individuals underwent cancer screening by fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) at our institution; 660 of 1498 asymptomatic healthy women underwent breast PET imaging in the prone position using the breast positioning device to examine the mammary glands in addition to whole-body PET imaging. All subjects that showed abnormal (18)F-FDG uptake in the mammary glands were referred for further examination or surgery at our institution or a local hospital. Our data were compared with the histopathological findings or findings of other imaging modalities in our institution and replies from the doctors at another hospital.

RESULTS

Of the 660 participants, 7 (1.06%) were found to have breast cancers at a curable stage. All the seven cancers were detected by breast PET imaging, but only five of these were detected by whole-body PET imaging; the other two were detected by breast PET imaging using the breast positioning device.

CONCLUSIONS

In cancer screening, prone breast imaging using a positioning device may help to improve the detection rate of breast cancer. However, overall cancer including mammography and ultrasonography screening should be performed to investigate the false-negative cases and reduce false-positive cases. The effectiveness of prone breast PET imaging in cancer screening should be investigated using a much larger number of cases in the near future.

摘要

目的

本研究旨在探讨使用乳腺定位装置的正电子发射断层扫描癌症筛查对乳腺癌的检出率。

方法

2004年1月至2006年1月期间,1498名健康无症状个体在本机构接受了氟-18氟脱氧葡萄糖正电子发射断层扫描(FDG-PET)癌症筛查;1498名无症状健康女性中的660名在俯卧位使用乳腺定位装置进行了乳腺PET成像,除全身PET成像外还对乳腺进行了检查。所有乳腺中显示异常(18)F-FDG摄取的受试者均被转介至本机构或当地医院进行进一步检查或手术。我们的数据与本机构的组织病理学结果或其他成像方式的结果以及另一家医院医生的回复进行了比较。

结果

在660名参与者中,发现7例(1.06%)处于可治愈阶段的乳腺癌。所有这7例癌症均通过乳腺PET成像检测到,但其中只有5例通过全身PET成像检测到;另外2例通过使用乳腺定位装置的乳腺PET成像检测到。

结论

在癌症筛查中,使用定位装置进行俯卧位乳腺成像可能有助于提高乳腺癌的检出率。然而,应进行包括乳房X线摄影和超声检查在内的全面癌症筛查,以调查假阴性病例并减少假阳性病例。俯卧位乳腺PET成像在癌症筛查中的有效性应在不久的将来使用更多病例进行研究。

相似文献

1
Improved detection of breast cancer on FDG-PET cancer screening using breast positioning device.使用乳房定位装置在FDG-PET癌症筛查中改善乳腺癌的检测。
Ann Nucl Med. 2008 Feb;22(2):95-101. doi: 10.1007/s12149-007-0092-1. Epub 2008 Mar 3.
2
Comparison of FDG PET and MRI for evaluating the tumor extent of breast cancer and the impact of FDG PET on the systemic staging and prognosis of patients who are candidates for breast-conserving therapy.氟代脱氧葡萄糖正电子发射断层扫描(FDG PET)与磁共振成像(MRI)在评估乳腺癌肿瘤范围方面的比较以及FDG PET对保乳治疗候选患者全身分期和预后的影响。
Breast Cancer. 2009;16(2):97-104. doi: 10.1007/s12282-008-0065-9. Epub 2008 Jul 29.
3
Effect of (18)F-FDG PET/CT imaging in patients with clinical Stage II and III breast cancer.(18)F-FDG PET/CT成像在临床II期和III期乳腺癌患者中的作用。
Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):695-704. doi: 10.1016/j.ijrobp.2008.02.056. Epub 2008 Apr 23.
4
Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.氟代脱氧葡萄糖摄取较低的乳腺癌:通过双时相氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描进行特征分析
Eur J Radiol. 2009 Jun;70(3):530-8. doi: 10.1016/j.ejrad.2008.01.045. Epub 2008 Apr 18.
5
Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.双时相18F-FDG PET在肺癌患者分期中的评估
J Nucl Med. 2008 Oct;49(10):1606-12. doi: 10.2967/jnumed.108.051250. Epub 2008 Sep 15.
6
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.与18F-FDG-PET相比,11C-蛋氨酸-PET在孤立性肺结节/肿块诊断中的可行性。
Ann Nucl Med. 2008 Jul;22(6):533-8. doi: 10.1007/s12149-007-0142-8. Epub 2008 Aug 1.
7
PET/CT for the staging and follow-up of patients with malignancies.正电子发射断层显像/计算机断层扫描用于恶性肿瘤患者的分期及随访。
Eur J Radiol. 2009 Jun;70(3):382-92. doi: 10.1016/j.ejrad.2009.03.051. Epub 2009 Apr 29.
8
Comparison of prone versus supine 18F-FDG-PET of locally advanced breast cancer: Phantom and preliminary clinical studies.局部晚期乳腺癌俯卧位与仰卧位18F-FDG-PET的比较:模型研究与初步临床研究
Med Phys. 2015 Jul;42(7):3801-13. doi: 10.1118/1.4921363.
9
Comparative study of FDG PET/CT and conventional imaging in the staging of rhabdomyosarcoma.18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层扫描(FDG PET/CT)与传统成像在横纹肌肉瘤分期中的对比研究
Ann Nucl Med. 2009 Feb;23(2):155-61. doi: 10.1007/s12149-008-0219-z. Epub 2009 Feb 19.
10
Detection of metastatic lesions from malignant pheochromocytoma and paraganglioma with diffusion-weighted magnetic resonance imaging: comparison with 18F-FDG positron emission tomography and 123I-MIBG scintigraphy.利用扩散加权磁共振成像检测恶性嗜铬细胞瘤和副神经节瘤的转移灶:与18F-FDG正电子发射断层扫描及123I-MIBG闪烁显像的比较
Ann Nucl Med. 2008 Jun;22(5):395-401. doi: 10.1007/s12149-008-0128-1. Epub 2008 Jul 4.

引用本文的文献

1
Prone versus Supine FDG PET/CT in the Staging of Breast Cancer.俯卧位与仰卧位氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在乳腺癌分期中的应用比较
Diagnostics (Basel). 2023 Jan 19;13(3):367. doi: 10.3390/diagnostics13030367.
2
Multimodal Patient-Specific Registration for Breast Imaging Using Biomechanical Modeling with Reference to AI Evaluation of Breast Tumor Change.基于生物力学建模并参考人工智能对乳腺肿瘤变化评估的乳腺成像多模态个体化配准
Life (Basel). 2021 Jul 26;11(8):747. doi: 10.3390/life11080747.
3
Potential Clinical Applications of F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Mammography in Breast Cancer.
F-氟脱氧葡萄糖正电子发射断层扫描/磁共振乳腺成像在乳腺癌中的潜在临床应用
Nucl Med Mol Imaging. 2017 Sep;51(3):217-226. doi: 10.1007/s13139-016-0446-5. Epub 2016 Aug 30.
4
Positron Emission Tomography in Breast Cancer.正电子发射断层扫描在乳腺癌中的应用。
Diagnostics (Basel). 2015 Mar 16;5(1):61-83. doi: 10.3390/diagnostics5010061.
5
Correlation between PET/CT results and histological and immunohistochemical findings in breast carcinomas.乳腺癌中PET/CT结果与组织学及免疫组化结果的相关性。
Radiol Bras. 2014 Mar-Apr;47(2):67-73. doi: 10.1590/S0100-39842014000200006.
6
Modern breast cancer detection: a technological review.现代乳腺癌检测:技术综述
Int J Biomed Imaging. 2009;2009:902326. doi: 10.1155/2009/902326. Epub 2009 Dec 28.
7
In vitro and in vivo analysis of [(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors.[(64)Cu-NO2A-8-Aoc-BBN(7-14)NH(2)]的体外和体内分析:一种用于T-47D人乳腺癌肿瘤正电子发射断层扫描成像的定点放射性药物。
Nucl Med Biol. 2009 Feb;36(2):171-81. doi: 10.1016/j.nucmedbio.2008.11.005.